Page 108 - MI-2-1
P. 108

Microbes & Immunity                                                      Advax-adjuvanted typhoid vaccine



               adjuvanted severe acute respiratory syndrome coronavirus   implications  after  vaccination  with  polysaccharide
               2 spike protein vaccine: A  phase 3 randomized placebo-  or glycoconjugate vaccines.  Expert  Rev  Vaccines.
               controlled trial. Clin Microbiol Infect. 2023;29:215-220.  2011;10:307-322.
               doi: 10.1016/j.cmi.2022.09.001                     doi: 10.1586/erv.11.8
            43.  Tabarsi  P,  Anjidani  N,  Shahpari  R,  et al.  Safety  and   49.  Keitel  WA,  Bond  NL,  Zahradnik  JM,  Cramton  TA,
               immunogenicity  of  SpikoGen(R),  an  Advax‑CpG55.2‑  Robbins  JB.  Clinical  and  serological  responses  following
               adjuvanted SARS‑CoV‑2 spike protein vaccine: A phase 2   primary and booster immunization with Salmonella typhi Vi
               randomized placebo-controlled trial in both seropositive   capsular polysaccharide vaccines. Vaccine. 1994;12:195-199.
               and seronegative populations.  Clin Microbiol Infect.      doi: 10.1016/0264-410x(94)90194-5
               2022;28:1263-1271.
                                                               50.  Yang  JS,  Kim  HJ,  Yun  CH,  et al. A  semi-automated
               doi: 10.1016/j.cmi.2022.04.004                     vibriocidal assay for improved measurement of cholera
            44.  Tabarsi P, Anjidani N, Shahpari R, et al. Immunogenicity   vaccine-induced immune responses.  J  Microbiol Methods.
               and  safety  of  SpikoGen(R),  an  adjuvanted  recombinant   2007;71:141-146.
               SARS‑CoV‑2  spike  protein  vaccine  as  a  homologous  and      doi: 10.1016/j.mimet.2007.08.009
               heterologous booster vaccination: A randomized placebo-
               controlled trial. Immunology. 2022;167:340-353.  51.  Maslanka SE, Gheesling LL, Libutti DE, et al. Standardization
                                                                  and a multilaboratory comparison of Neisseria meningitidis
               doi: 10.1111/imm.13540                             serogroup  A  and  C  serum  bactericidal  assays.  The
            45.  Sakala  IG,  Eichinger  KM,  Petrovsky  N.  Neonatal  vaccine   Multilaboratory  Study  Group.  Clin Diagn Lab Immunol.
               effectiveness and the role of adjuvants.  Expert Rev Clin   1997;4:156-167.
               Immunol. 2019;15:869-878.                          doi: 10.1128/cdli.4.2.156-167.1997
               doi: 10.1080/1744666X.2019.1642748              52.  Pulickal AS, Gautam S, Clutterbuck EA, et al. Kinetics of the
            46.  Honda‑Okubo Y, Ong CH, Petrovsky N. Advax delta inulin   natural, humoral immune response to Salmonella enterica
               adjuvant overcomes immune immaturity in neonatal mice   serovar Typhi in Kathmandu, Nepal. Clin Vaccine Immunol.
               thereby allowing single-dose influenza vaccine protection.   2009;16:1413-1419.
               Vaccine. 2015;33:4892-4900.                        doi: 10.1128/CVI.00245‑09
               doi: 10.1016/j.vaccine.2015.07.051              53.  Feasey NA, Levine MM. Typhoid vaccine development with
            47.  Sakala IG, Honda‑Okubo Y, Li L, Baldwin J, Petrovsky N.   a human challenge model. Lancet. 2017;390:2419-2421.
               A M2 protein‑based universal influenza vaccine containing      doi: 10.1016/S0140-6736(17)32407-8
               Advax‑SM  adjuvant  provides  newborn  protection   54.  Waddington  CS,  Darton  TC,  Woodward  WE,  Angus  B,
               via maternal or neonatal immunization.  Vaccine.   Levine  MM,  Pollard  AJ.  Advancing  the  management  and
               2021;39:5162-5172.
                                                                  control of typhoid fever: A review of the historical role of
               doi: 10.1016/j.vaccine.2021.07.037                 human challenge studies. J Infect. 2014;68:405-418.
            48.  Poolman J, Borrow R. Hyporesponsiveness and its clinical      doi: 10.1016/j.jinf.2014.01.006



























            Volume 2 Issue 1 (2025)                        100                               doi: 10.36922/mi.4497
   103   104   105   106   107   108   109   110   111   112   113